Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847

Article  PubMed  Google Scholar 

Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al (2016) American heart association statistics committee; stroke statistics subcommittee. Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation 133:e38–e360

Google Scholar 

Alonso A, Bengtson LG (2014) A rising tide: the global epidemic of atrial fibrillation. Circulation 129:829–830

Article  PubMed  Google Scholar 

Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137–1146

Article  PubMed  PubMed Central  Google Scholar 

Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al (2012) American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics – 2012 update: a report from the american heart association. Circulation 125:e2–e220

PubMed  Google Scholar 

Sakata Y, Shimokawa H (2013) Epidemiology of heart failure in Asia. Circ J 77(9):2209–2217

Article  PubMed  Google Scholar 

Feitell S, Hankins SR, Eisen HJ (2014) Adjunctive therapy and management of the transition of care in patients with heart failure. Cardiol Clin 32(1):163–174

Article  PubMed  Google Scholar 

Mohammed KS, Kowey PR, Musco S (2010) Adjuvant therapy for atrial fibrillation. Future Cardiol 6(1):67–81

Article  PubMed  Google Scholar 

Chen J, Wei X, Zhang Q, Wu Y, Xia G, Xia H, Wang L, Shang H, Lin S (2023) The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms. Acta Pharm Sin B 13(5):1919–1955

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao X, Liu H, Zhou M, Chen X, Long D (2022) Comparative efficacy of five Chinese medicine injections for treating dilated cardiomyopathy with heart failure: a Bayesian network meta-analysis. J Ethnopharmacol 282:114604

Article  CAS  PubMed  Google Scholar 

Cao X, Zhou M, Liu H, Chen X, Li X, Jia S (2021) Clinical efficacy and safety of Shensong Yangxin capsule-amiodarone combination on heart failure complicated by ventricular arrhythmia: a meta-analysis of randomized controlled trials. Front Pharmacol 12:613922

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li XX, Wu Y, Fan ZJ, Cui J, Li D, Lin Q et al (2022) Qishen Taohong Granule as adjuvant therapy for improving cardiac function and quality of life in patients with chronic heart failure: a randomized controlled trial. Chin J Integr Med 28:12e9

Article  Google Scholar 

Han JY, Li Q, Ma ZZ, Fan JY (2017) Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion. Pharmacol Ther 177:146e73

Article  Google Scholar 

Fan XG, Tang N, Ji YX, Zhang YZ, Jiang L, Huang GH et al (2015) Explration of the essence of “endogenous turbidity” in Chinese medicine. Chin J Integr Tradit West Med 35:1011e4

Google Scholar 

National Health Research Institutes. National Health Insurance Research Database. http://nhird.nhri.org.tw/en/index.html (accessed April 14, 2015).

Liu ZH, Liu HB, Wang J (2018) Astragaloside IV protects against the pathological cardiac hypertrophy in mice. Biomed Pharmacother 97:1468e78

Article  Google Scholar 

Zhang ZL, Fan Y, Liu ML (2012) Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia/reoxygenation. Mol Cell Biochem 365:243e50

Article  Google Scholar 

Liu G, Qi X, Li X, Sun F (2021) Ginsenoside Rg2 protects cardiomyocytes against trastuzumab-induced toxicity by inducing autophagy. Exp Ther Med 21:473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Cui Y, Xiong M, Li M, Wang P, Cui J et al (2021) Dual activity of ginsenoside Rb1 in hypertrophic cardiomyocytes and activated macrophages: implications for the therapeutic intervention of cardiac hypertrophy. J Inflamm Res 14:1789e806

Google Scholar 

Sun J, Yu X, Huangpu H, Yao F (2019) Ginsenoside Rb3 protects cardiomyocytes against hypoxia/reoxygenation injury via activating the antioxidation signaling pathway of PERK/Nrf2/HMOX1. Biomed Pharmacother 109:254e61

Article  Google Scholar 

Huang Q, Su H, Qi B, Wang Y, Yan K, Wang X et al (2021) A SIRT1 activator, ginsenoside Rc, promotes energy metabolism in cardiomyocytes and neurons. J Am Chem Soc 143:1416e27

Google Scholar 

McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995e2008

Article  Google Scholar 

Yu Y, Sun G, Luo Y, Wang M, Chen R, Zhang J et al (2016) Cardioprotective effects of notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress-related signaling pathways. Sci Rep 6:21730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Wu Y, Qin X, Wen P, Liu J, Yang M (2021) Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng saponins in ischemic cardiomyocytes. J Ethnopharmacol 268:113639

Article  CAS  PubMed  Google Scholar 

Chen J, Wang Y, Wang S, Zhao X, Zhao L, Wang Y (2022) Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling. J Ethnopharmacol 283:114667

Article  CAS  PubMed  Google Scholar 

Zhang XJ, Cui ZH, Zhao YX, He TT, Wang L, Liang XW (2021) Ferulic acid ameliorates isoproterenol-induced heart failure by decreasing oxidative stress and inhibiting cardiocyte apoptosis via activating Nrf2 signaling pathway in rats. Biol Pharm Bull 44:396e403

Article  Google Scholar 

Li F, Fan XX, Chu C, Zhang Y, Kou JP, Yu BY (2018) A strategy for optimizing the combination of active components based on Chinese medicinal formula Sheng-Mai-San for myocardial ischemia. Cell Physiol Biochem 45:1455e71

Article  Google Scholar 

Gardiner P, Graham R, Legedza AT, Ahn AC, Eisenberg DM, Phillips RS (2007) Factors associated with herbal therapy use by adults in the United States. Altern Ther Health Med 13:22–29

PubMed  Google Scholar 

Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 12:1–23

Google Scholar 

Layne K, Ferro A (2017) Traditional Chinese medicines in the management of cardiovascular diseases: a comprehensive systematic review. Br J Clin Pharmacol 83:20–32

Article  PubMed  Google Scholar 

Ren W, Wang M, Liao J, Li L, Yang D, Yao R et al (2020) The effect of Chinese herbal medicine combined with western medicine on vascular endothelial function in patients with hypertension: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 11:823

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beik A, Joukar S, Najafipour H (2020) A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs. J Tradit Complement Med 10(3):275–287

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Li N, Jia Z, Lu F, Pu J (2014) Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial. Evid Based Complement Alternat Med 2014:605714

Article  PubMed  PubMed Central  Google Scholar